These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35854065)

  • 1. Autocrine pro-legumain promotes breast cancer metastasis via binding to integrin αvβ3.
    Liu C; Wang J; Zheng Y; Zhu Y; Zhou Z; Liu Z; Lin C; Wan Y; Wen Y; Liu C; Yuan M; Zeng YA; Yan Z; Ge G; Chen J
    Oncogene; 2022 Aug; 41(34):4091-4103. PubMed ID: 35854065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Legumain Is an Endogenous Modulator of Integrin αvβ3 Triggering Vascular Degeneration, Dissection, and Rupture.
    Pan L; Bai P; Weng X; Liu J; Chen Y; Chen S; Ma X; Hu K; Sun A; Ge J
    Circulation; 2022 Mar; 145(9):659-674. PubMed ID: 35100526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anticancer properties and mechanism of action of tablysin-15, the RGD-containing disintegrin, in breast cancer cells.
    Deng Z; Chai J; Zeng Q; Zhang B; Ye T; Chen X; Xu X
    Int J Biol Macromol; 2019 May; 129():1155-1167. PubMed ID: 30660566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BKCa promotes growth and metastasis of prostate cancer through facilitating the coupling between αvβ3 integrin and FAK.
    Du C; Zheng Z; Li D; Chen L; Li N; Yi X; Yang Y; Guo F; Liu W; Xie X; Xie M
    Oncotarget; 2016 Jun; 7(26):40174-40188. PubMed ID: 27233075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes αvβ3-mediated adhesion and invasive migration.
    Liao SJ; Zhou YH; Yuan Y; Li D; Wu FH; Wang Q; Zhu JH; Yan B; Wei JJ; Zhang GM; Feng ZH
    Breast Cancer Res Treat; 2012 Jun; 133(3):853-63. PubMed ID: 22042369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling.
    Luo J; Yao JF; Deng XF; Zheng XD; Jia M; Wang YQ; Huang Y; Zhu JH
    J Exp Clin Cancer Res; 2018 Feb; 37(1):23. PubMed ID: 29426357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Legumain-deficient macrophages promote senescence of tumor cells by sustaining JAK1/STAT1 activation.
    Shen L; Kang L; Wang D; Xun J; Chen C; Du L; Zhang M; Gong J; Mi X; Yue S; Zhang Y; Song X; Xiang R; Zhang Z; Tan X
    Cancer Lett; 2020 Mar; 472():40-49. PubMed ID: 31857155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.
    D'Costa ZC; Higgins C; Ong CW; Irwin GW; Boyle D; McArt DG; McCloskey K; Buckley NE; Crawford NT; Thiagarajan L; Murray JT; Kennedy RD; Mulligan KA; Harkin DP; Waugh DJ; Scott CJ; Salto-Tellez M; Williams R; Mullan PB
    Oncotarget; 2014 Mar; 5(6):1609-20. PubMed ID: 24742492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemically Programmed Bispecific Antibody Targeting Legumain Protease and αvβ3 Integrin Mediates Strong Antitumor Effects.
    Liu Y; Goswami RK; Liu C; Sinha SC
    Mol Pharm; 2015 Jul; 12(7):2544-50. PubMed ID: 26024761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of an Integrin α
    Gai Y; Jiang Y; Long Y; Sun L; Liu Q; Qin C; Zhang Y; Zeng D; Lan X
    Mol Pharm; 2020 Jan; 17(1):349-358. PubMed ID: 31829615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of αvβ3 integrin-overexpressing breast cancer cells.
    Shan D; Li J; Cai P; Prasad P; Liu F; Rauth AM; Wu XY
    Drug Deliv Transl Res; 2015 Feb; 5(1):15-26. PubMed ID: 25787336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone sialoprotein-αvβ3 integrin axis promotes breast cancer metastasis to the bone.
    Wang L; Song L; Li J; Wang Y; Yang C; Kou X; Xiao B; Zhang W; Li L; Liu S; Wang J
    Cancer Sci; 2019 Oct; 110(10):3157-3172. PubMed ID: 31432600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Overview of Targeting Legumain for Inhibiting Cancers.
    Reddy BD; Beeraka NM; Chitturi CMK; Madhunapantula SV
    Curr Pharm Des; 2021 Oct; 27(31):3337-3348. PubMed ID: 33238867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RGD binding to integrin alphavbeta3 affects cell motility and adhesion in primary human breast cancer cultures.
    Georgoulis A; Havaki S; Drosos Y; Goutas N; Vlachodimitropoulos D; Aleporou-Marinou V; Kittas C; Marinos E; Kouloukoussa M
    Ultrastruct Pathol; 2012 Dec; 36(6):387-99. PubMed ID: 23181508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer Cell Secreted Legumain Promotes Gastric Cancer Resistance to Anti-PD-1 Immunotherapy by Enhancing Macrophage M2 Polarization.
    Pei X; Zhang SL; Qiu BQ; Zhang PF; Liu TS; Wang Y
    Pharmaceuticals (Basel); 2024 Jul; 17(7):. PubMed ID: 39065799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrin αvβ3-associated DAAM1 is essential for collagen-induced invadopodia extension and cell haptotaxis in breast cancer cells.
    Yan T; Zhang A; Shi F; Chang F; Mei J; Liu Y; Zhu Y
    J Biol Chem; 2018 Jun; 293(26):10172-10185. PubMed ID: 29752407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lunasin suppresses the migration and invasion of breast cancer cells by inhibiting matrix metalloproteinase-2/-9 via the FAK/Akt/ERK and NF-κB signaling pathways.
    Jiang Q; Pan Y; Cheng Y; Li H; Liu D; Li H
    Oncol Rep; 2016 Jul; 36(1):253-62. PubMed ID: 27175819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Legumain Promotes Gastric Cancer Progression Through Tumor-associated Macrophages
    Wang H; Chen B; Lin Y; Zhou Y; Li X
    Int J Biol Sci; 2020; 16(1):172-180. PubMed ID: 31892854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting cell surface alpha(v)beta(3) integrin increases therapeutic efficacies of a legumain protease-activated auristatin prodrug.
    Liu Y; Bajjuri KM; Liu C; Sinha SC
    Mol Pharm; 2012 Jan; 9(1):168-75. PubMed ID: 22044266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiRNA-3978 regulates peritoneal gastric cancer metastasis by targeting legumain.
    Zhang Y; Wu YY; Jiang JN; Liu XS; Ji FJ; Fang XD
    Oncotarget; 2016 Dec; 7(50):83223-83230. PubMed ID: 27793040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.